Ultrafast CT developer Imatron has revised its product development and distribution agreementwith Siemens, the South San Francisco, CA, company reported lastweek. Under the terms of the new deal, Siemens will contribute$15 million toward a three-year
Ultrafast CT developer Imatron has revised its product development and distribution agreementwith Siemens, the South San Francisco, CA, company reported lastweek. Under the terms of the new deal, Siemens will contribute$15 million toward a three-year collaborative research programto upgrade Imatron's C-150 CT scanner, marketed by Siemens asEvolution EBT. Siemens will also cancel a $4 million loan to Imatronfor the transfer of Imatron patents to Siemens.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.